Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group. - Li R; Hensley PJ; Babjuk M; Bukavina L; Psutka SP; Lerner SP; O'Donnell MA; Lotan Y; Bree KK; Redorta JP; McConkey DJ; Lee BH; et al. (European urology oncology, 2025)